A 40 year old female with Stage IA Hodgkins Lymphoma Tuesday, August - - PowerPoint PPT Presentation

A 40 year old female with Stage IA Hodgkin’s Lymphoma

Tuesday, August 8, 2017

Dr Ayasuddin Mohammed Dr Patrick Manshimba

Continuing Medical Education Announcement

Harvard Medical School RSS 3081: Monthly BOTSOGO Tumor Board; 2017-2018 Academic Year Today’s ObjecKves:

• Describe the need for Kmely cancer case presentaKon and referral to

treatment

• Formulate a mulK-disciplinary plan for the care of common and complex
• ncologic cases
• Adopt successful, sustainable strategies to miKgate barriers to quality

cancer care common in resource constrained environments Target Audience: Oncologists, internists, surgeons, radiaKon oncologists, infecKous disease specialists, nurses, physicists, therapists, technicians, research staff, administrators, policy makers.

Financial Relationships

The following planners, speakers, and content reviewers, on behalf of themselves and their spouse or partner, have reported financial relaKonships with an enKty producing, markeKng, re-selling, or distribuKng health care goods or services (relevant to the content of the acKvity) consumed by, or used on, paKents: All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a posiKon to control the content of this educaKonal acKvity have reported no financial relaKonships related to the content of this acKvity

Name Role Type of Financial RelaConship

Philippe Armand, MD Speaker BMS – consultant, insKtuKonal research funding Merck – consultant, insKtuKonal research funding Pfizer – consultant, insKtuKonal research funding Affimed – insKtuKonal research funding Sequenta – insKtuKonal research funding Roche – insKtuKonal research funding Tensha – insKtuKonal research funding

Statements

AccreditaCon Statement The Harvard Medical School is accredited by the AccreditaKon Council for ConKnuing Medical EducaKon to provide conKnuing medical educaKon for physicians Credit DesignaCon Statement The Harvard Medical School designates this live acKvity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their parKcipaKon in the acKvity This acKvity meets the criteria of the Massachuse^s Board of RegistraKon in Medicine for 1.0 credits of Risk Management Study Disclosure Statement In accord with the disclosure policy of the Medical School as well as standards set forth by the AccreditaKon Council for ConKnuing Medical EducaKon, course planners, speakers, and content reviewers have been asked to disclose any relevant relaKonship they, or their spouse or partner, have to companies producing, markeKng, re-selling or distribuKng health care goods or services consumed by, or used on, paKents.

Claim your CME credits!

• To claim your CME credit for a^endance at this

session of the BOTSOGO Tumor Board, please fill out

• ur survey a`er the Tumor Board.
• You can do this at your convenience on your personal
• r work computer by navigaKng to www.botsogo.org
• Click “What We Do”
• Click “Tumor Board”
• Click the link under the secKon “ConKnuing EducaKon

Credits,” and complete and submit the survey

• Or follow the link that was emailed to our MGH

BOTSOGO email list: www.Knyurl.com/tumourboard

• A 40 year old female, seronegaKve
• In October 2016, the paKent consulted for a right

cervical lymphadenopathy without B symptoms. And an FNA followed by excisional biopsy of a 2.2cm node in March 2017 showed a Hodgkin’s lymphoma, mixed cell type, CD30 and CD15 posiKve;CD20 focally posiKve.

• The clinical exam noted a non bulky LAD involving only

the right cervical chain.

• The CT chest/abdomen/pelvis from October 2016

showed no addiKonal sites of disease.

History of Present Illness

History of Present Illness

• She was iniKated on chemotherapy ABVD regimen

fortnightly from October 2016 to March 2017 she completed the fourth cycle; and the paKent was referred to GPH for RT

• At G.P.H, a planning CT scan was done and didn’t show

any evidence of disease in the neck. RT was postponed in favor of a PET CT recommended

• The PET CT from May 2017 showed no residual disease.

GPH recommended conKnued surveillance to avoid undue toxicity from RT.

• HIV negaKve;
• Family history of cancer: breast cancer

(grandmother & sister);

• No history of TB, HTN or DM;
• No known allergies;
• Non smoker & does not drink alcohol;
• Married and mother of 3.
• Teacher;
• Lives in Gaborone.

Past medical history

Currently

• No symptoms
• On examinaKon:
• Stable PaKent with Good nutriKonal status
• No weight lost
• Loco-regional examinaKon: NAD
• A/P 40 yo female, seronegaKve, diagnosed

with stage IA; favorable Hodgkin lymphoma. Post chemotherapy 4 cycles of ABVD with a negaKve PET CT

• Place for RT at this stage? If not:
• Does she need 2 more cycles of chemo as she

absorbed only 4?

• Should she conKnue follow up with repeated CT

scan at 6 months?

Discussion and Questions